U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Conversations on Cancer- LBGTQ plus OCE: A Voice in Clinical Trials - 06/23/2020 - 06/23/2020
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
Conversations on Cancer- LBGTQ plus OCE: A Voice in Clinical Trials
June 23, 2020


Date:
June 23, 2020
Organized By:

Speakers:

Dr. Richard Pazdur is the director of the FDA's Oncology Center of Excellence (OCE).

Kellan Baker is the Centennial Scholar and a Robert Wood Johnson Health Policy Research Scholar in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.

D Magrini is the Assistant Director of Community Commitment, Whiteman-Walker Health (WWH) and cancer survivor.

Joshua Riley is a licensed professional counselor (LPC) and serves as Director of Community Commitment at Whitman-Walker Health.

NFN Scout is the Deputy Director of the National LGBT Cancer Network and the principal investigator of the CDC-funded LGBTQ tobacco-related cancer disparity network.

Dr. Karen Winkfield is a Radiation Oncologist specializing in the management of cancers of the breast and blood who has written several articles and book chapters focused on treatment-related toxicities in cancer survivorship.

Moderator:

Rea Blakey, Associate Director of External Outreach and Engagement, Oncology Center of Excellence, FDA

Dr. Jamie Brewer is a medical oncologist and clinical reviewer on the Genitourinary Cancer team in the Office of Oncologic Diseases (OOD)

Background:

Conversations on Cancer - Making Cancer Personal at the FDA” is an educational lecture series for FDA staff. Please join the OCE Conversations on Cancer titled “LGBTQ + OCE= A Voice in Clinical Trials and Cancer Drug Development” on Tuesday, June 23rd at 1:00 pm (EDT) through WebEx. The one-hour conversation will include topics such as barriers for inclusion in clinical trials and bridging knowledge gaps for specific types of cancers in this vulnerable population.

Webcast Information:

FDA provided a free-of-charge, live webcast of this workshop.

Contact:

For additional information, please send an email to: OCE-Engagement@fda.hhs.gov

 
Back to Top